Back to 
BlackRock, Inc.
BlackRock, Inc.
BBOT4 quarters
Position history for BlackRock, Inc.'s holdings in BRIDGEBIO ONCOLOGY THERAPEUT
BlackRock, Inc. holds 2.2M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $16.4M as of 2026-Q2. The position was increased (+3.1% shares). BBOT represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$16.4M
Current Shares
2.2M
Total Value Change
-$7.3M
Total Shares Change
+105,488
Quarter-by-Quarter History
Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC